Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

被引：0
|
作者：
Yanwen Yao
Dongmei Yuan
Hongbing Liu
Xiaoling Gu
Yong Song
机构：
[1] Jinling Hospital,Department of Respiratory Medicine
[2] Nanjing University School of Medicine,undefined
来源：
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词：
Neutrophil to lymphocyte ratio; Prognostic factor; Tumor-related inflammation; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 479
页数：8
相关论文
共 50 条
  • [1] Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Yao, Yanwen
    Yuan, Dongmei
    Liu, Hongbing
    Gu, Xiaoling
    Song, Yong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) : 471 - 479
  • [2] Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer
    Liu, Hongbing
    Wu, Ying
    Wang, Zhaofeng
    Yao, Yanwen
    Chen, Fangfang
    Zhang, He
    Wang, Yunfen
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2013, 5 (06) : 783 - 789
  • [3] Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients
    Song, Ying-Jian
    Wang, Li-Xin
    Hong, Yong-Qing
    Lu, Zheng-Hong
    Tong, Qiang
    Fang, Xiao-Zheng
    Tan, Juan
    TUMOR BIOLOGY, 2016, 37 (04) : 5285 - 5293
  • [4] Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy
    Ma, Kewei
    Xu, Wang
    Wang, Chang
    Li, Biao
    Su, Keju
    Li, Wei
    CANCER BIOMARKERS, 2017, 18 (03) : 297 - 303
  • [5] Pretreatment Inflammatory Indexes are Associated with Response to First-Line Platinum-Based Chemotherapy and Prognosis of Small Cell Lung Cancer Patients
    Inanc, Mevlude
    Bozkurt, Oktay
    Ocak Duran, Ayse
    Ozkan, Metin
    Altinbas, Mustafa
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (02): : 79 - 87
  • [6] Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
    Guo, Dong
    Li, Minghuan
    Chen, Dawei
    Jing, Wang
    Zhu, Hui
    Fu, Lei
    Kong, Li
    Yue, Jinbo
    Yu, Jinming
    FUTURE ONCOLOGY, 2019, 15 (06) : 625 - 635
  • [7] New options for integrating antiangiogenic therapy and platinum-based first-line chemotherapy for advanced non-small cell lung cancer
    Manegold, Christian
    CLINICAL LUNG CANCER, 2008, 9 : S100 - S108
  • [8] Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Xu, X. -L.
    Yao, Y. -L.
    Xu, W. -Z.
    Feng, J. -G.
    Mao, W. -M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3525 - 3533
  • [9] Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer
    Fang, Shu
    Wang, Zhehai
    Guo, Jun
    Liu, Jie
    Li, Changzheng
    Liu, Lin
    Shi, Huan
    Liu, Liyan
    Li, Huihui
    Xie, Chao
    Zhang, Xia
    Sun, Wenwen
    Li, Minmin
    ONCOTARGETS AND THERAPY, 2014, 7 : 1185 - 1193
  • [10] Prognosis of Advanced Non-Small Cell Lung Cancer (NSCLC) Refractory to First-Line Platinum Chemotherapy
    Ahn, Hee Kyung
    Kim, Young Saing
    Kim, Eun Young
    Kyung, Sun Young
    Kang, Shin Myung
    Cho, Eun Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S910 - S911
12345